Lexaria Bioscience (LEXX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lexaria Bioscience has formed a new Scientific Advisory Board to enhance its drug delivery platform technology, with John Docherty, a seasoned expert in the pharmaceutical sector, as the Chairman. The board, comprising experts in pharmaceutical development, aims to guide the company’s strategic plans towards successful commercialization.
For further insights into LEXX stock, check out TipRanks’ Stock Analysis page.